Aprazer Healthcare Launched PIRFEKAST

Posted by

Aprazer

On June 30, 2021

Comments Off

Launch Date: 30/06/2021

Aprazer Healthcare Launched PIRFEKAST (Pirfenidone) which is a medication indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

Older Aprazer Healthcare to manufacture world class Oncology Drugs at state-of-the-art Manufacturing facility

Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.